Skip to main
ACHC
ACHC logo

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 25%
Hold 33%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc demonstrates a positive outlook primarily due to its robust organic growth fueled by expansions in bed capacity and new facility developments, alongside a significant increase in specialty treatment admissions. The company's strong capitalization supports its capacity for mergers and acquisitions, positioning it well to capitalize on the growing demand in the behavioral healthcare sector. Furthermore, planned reductions in capital expenditures anticipated for 2026 are expected to enhance cash flow, contributing to a solid financial foundation moving forward.

Bears say

Acadia Healthcare Co. Inc. has faced significant challenges leading to a consistently negative outlook, primarily due to heightened PLGL expenses that are projected to persist until at least 2026. The company's recent revisions indicate a 13.4% reduction in full-year 2025 adjusted EBITDA guidance, reflecting ongoing volume softness and rate pressure, with future EBITDA estimates for 2026 also being lowered significantly. These ongoing financial pressures and the anticipated contraction in enterprise value, alongside a decline in capital expenditures, suggest a downward trajectory for the company's financial performance in the near term.

Acadia Healthcare (ACHC) has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 25% recommend Buy, 33% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 12 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Dec 17, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.